Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
May 22, 2017 SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
May 15, 2017 8-K

Report of unscheduled material events or corporate event

View HTML
May 9, 2017 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
May 1, 2017 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
May 1, 2017 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
April 25, 2017 8-K

Report of unscheduled material events or corporate event

View HTML
April 4, 2017 4

Statement of changes in beneficial ownership of securities

View HTML
April 4, 2017 4

Statement of changes in beneficial ownership of securities

View HTML
April 4, 2017 4

Statement of changes in beneficial ownership of securities

View HTML
March 31, 2017 CT ORDER

CT ORDER

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us